Connect with us
After markets closed on Wednesday, MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) announced its financial results for the third quarter ended Sept. 30. MariMed reported that its...
The Zig-Zag maker now expects adjusted EBITDA of $101 million-$103 million for 2024. Turning Point Brands (NYSE: TPB) beat analyst estimates and raised its full-year outlook...
This story was republished with permission from Crain’s Chicago. Cannabis stocks got crushed the day after a recreational-use referendum failed in Florida, which would have become one...
Hydrofarm maintained its full-year outlook, expecting sales to decline in the “low to high teens” percentage range. Pennsylvania-based Hydrofarm Holdings Group Inc. (Nasdaq: HYFM) financials took...
Ireland-based Jazz Pharmaceuticals (Nasdaq: JAZZ), the makers of Epidiolex, reported net income in the third quarter this year of $215 million, with revenue up 9% year-over-year....
Florida voters rejected recreational marijuana legalization Tuesday night, dealing a huge blow to the industry and those that had bet heavily on opening up what could...
Capital fundraising across cannabis is still down year-over-year, according to ongoing market research by Viridian Capital Advisors, with 124 capital raises over the last 12 months...
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced its financial results for the fiscal 2025 second quarter. Total revenue rose year-over-year and the company has a...
Scotts Miracle-Gro Company (NYSE: SMG) announced its results for the full year and fourth quarter ended September 30, 2024. Sales increased and beat analysts’ estimates, but...
Trulieve Cannabis Corp. (OTC: TCNNF) reported Tuesday that its third-quarter revenue grew 3% to $284 million, falling short of analysts’ expectations amid heavy investment in Florida’s...
